Myopia management is a new and rapidly evolving therapeutic area designed to slow down the spread of the condition and reduce the risk of vision loss and blindness. With new treatments emerging, new research to interpret and new clinical challenges to address, clinicians are struggling to get to grips with the demands of myopia control.
We have developed a unique portfolio of tools to help eye care practitioners communicate and explain the rationale and options of myopia management to their patients. Ocumetra provides the answers clinicians need to deliver personalised, adaptive eye care to every myopia patient.
Ocumetra's ambition is to make ocular growth analysis a core component of clinical care for myopia, to make the Ocumetra brand synonymous with comprehensive myopia care and to deliver the clinical tools that every ophthalmic practitioner managing myopia will need.
Meet the co-founders, Ian the Ophthalmologist and James the Optometrist, working together on their shared passion for all things myopia. With more than €10 million research funding, over 120 scientific papers published, countless lectures delivered and numerous clinical trials ongoing, understanding myopia and delivering ways to get it under control represents the core focus of their work.
James Loughman PhD
Co-Founder / Optometrist
Ian Flitcroft D.Phil FRCOphth
Co-Founder / Ophthalmologist
Kate Loskutova, MBBS, PhD
Director of Operations
Alexandru Constantin Cardas
Data Scientist & Software Engineer
Clinical Research Consultant
Davoud Shariat Panah
Regulatory Affairs Officer